Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 4
2007 3
2008 2
2009 2
2010 4
2011 2
2012 5
2013 2
2014 4
2015 4
2016 7
2017 4
2018 4
2019 7
2020 4
2021 5
2023 7
2024 6
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
Scully M, Cataland SR, Peyvandi F, Coppo P, Knöbl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, Biswas D, De Winter H, Zeldin RK; HERCULES Investigators. Scully M, et al. N Engl J Med. 2019 Jan 24;380(4):335-346. doi: 10.1056/NEJMoa1806311. Epub 2019 Jan 9. N Engl J Med. 2019. PMID: 30625070 Free article. Clinical Trial.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.
Connolly SJ, Sharma M, Cohen AT, Demchuk AM, Członkowska A, Lindgren AG, Molina CA, Bereczki D, Toni D, Seiffge DJ, Tanne D, Sandset EC, Tsivgoulis G, Christensen H, Beyer-Westendorf J, Coutinho JM, Crowther M, Verhamme P, Amarenco P, Roine RO, Mikulik R, Lemmens R, Veltkamp R, Middeldorp S, Robinson TG, Milling TJ Jr, Tedim-Cruz V, Lang W, Himmelmann A, Ladenvall P, Knutsson M, Ekholm E, Law A, Taylor A, Karyakina T, Xu L, Tsiplova K, Poli S, Kallmünzer B, Gumbinger C, Shoamanesh A; ANNEXA-I Investigators. Connolly SJ, et al. N Engl J Med. 2024 May 16;390(19):1745-1755. doi: 10.1056/NEJMoa2313040. N Engl J Med. 2024. PMID: 38749032 Free article. Clinical Trial.
Heparanase in the Coagulation System.
Nadir Y. Nadir Y. Adv Exp Med Biol. 2020;1221:771-784. doi: 10.1007/978-3-030-34521-1_33. Adv Exp Med Biol. 2020. PMID: 32274737 Review.
Heparanase procoagulant activity.
Nadir Y, Brenner B. Nadir Y, et al. Thromb Res. 2012 Apr;129 Suppl 1:S76-9. doi: 10.1016/S0049-3848(12)70021-X. Thromb Res. 2012. PMID: 22682139
Tissue factor-heparanase complex: intracellular nonhemostatic effects.
Ghanem S, Keren-Politansky A, Kaplan V, Crispel Y, Nadir Y. Ghanem S, et al. Among authors: nadir y. Res Pract Thromb Haemost. 2023 Aug 30;7(6):102179. doi: 10.1016/j.rpth.2023.102179. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37767062 Free PMC article.
Heparanase, tissue factor, and cancer.
Nadir Y, Vlodavsky I, Brenner B. Nadir Y, et al. Semin Thromb Hemost. 2008 Mar;34(2):187-94. doi: 10.1055/s-2008-1079259. Semin Thromb Hemost. 2008. PMID: 18645924 Review.
78 results